SG159458A1 - Novel immunoglobulin-binding proteins with improved specificity - Google Patents

Novel immunoglobulin-binding proteins with improved specificity

Info

Publication number
SG159458A1
SG159458A1 SG200905295-2A SG2009052952A SG159458A1 SG 159458 A1 SG159458 A1 SG 159458A1 SG 2009052952 A SG2009052952 A SG 2009052952A SG 159458 A1 SG159458 A1 SG 159458A1
Authority
SG
Singapore
Prior art keywords
binding proteins
improved specificity
novel immunoglobulin
specificity
improved
Prior art date
Application number
SG200905295-2A
Other languages
English (en)
Inventor
Shari Spector
Original Assignee
Millipore Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Millipore Corp filed Critical Millipore Corp
Publication of SG159458A1 publication Critical patent/SG159458A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1267—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-positive bacteria
    • C07K16/1271—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-positive bacteria from Micrococcaceae (F), e.g. Staphylococcus
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/16—Extraction; Separation; Purification by chromatography
    • C07K1/22—Affinity chromatography or related techniques based upon selective absorption processes
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J20/00—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof
    • B01J20/281—Sorbents specially adapted for preparative, analytical or investigative chromatography
    • B01J20/286—Phases chemically bonded to a substrate, e.g. to silica or to polymers
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J20/00—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof
    • B01J20/30—Processes for preparing, regenerating, or reactivating
    • B01J20/32—Impregnating or coating ; Solid sorbent compositions obtained from processes involving impregnating or coating
    • B01J20/3231—Impregnating or coating ; Solid sorbent compositions obtained from processes involving impregnating or coating characterised by the coating or impregnating layer
    • B01J20/3242—Layers with a functional group, e.g. an affinity material, a ligand, a reactant or a complexing group
    • B01J20/3268—Macromolecular compounds
    • B01J20/3272—Polymers obtained by reactions otherwise than involving only carbon to carbon unsaturated bonds
    • B01J20/3274—Proteins, nucleic acids, polysaccharides, antibodies or antigens
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/305—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Micrococcaceae (F)
    • C07K14/31—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Micrococcaceae (F) from Staphylococcus (G)

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
SG200905295-2A 2008-08-11 2009-08-07 Novel immunoglobulin-binding proteins with improved specificity SG159458A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US18854908P 2008-08-11 2008-08-11
US21281209P 2009-04-16 2009-04-16

Publications (1)

Publication Number Publication Date
SG159458A1 true SG159458A1 (en) 2010-03-30

Family

ID=41258393

Family Applications (2)

Application Number Title Priority Date Filing Date
SG2013066568A SG193852A1 (en) 2008-08-11 2009-08-07 Novel immunoglobulin-binding proteins with improved specificity
SG200905295-2A SG159458A1 (en) 2008-08-11 2009-08-07 Novel immunoglobulin-binding proteins with improved specificity

Family Applications Before (1)

Application Number Title Priority Date Filing Date
SG2013066568A SG193852A1 (en) 2008-08-11 2009-08-07 Novel immunoglobulin-binding proteins with improved specificity

Country Status (7)

Country Link
US (2) US8592555B2 (fr)
EP (3) EP2495253B1 (fr)
JP (3) JP5480558B2 (fr)
CN (3) CN104804073B (fr)
ES (3) ES2612166T3 (fr)
IN (1) IN2015DE00245A (fr)
SG (2) SG193852A1 (fr)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8592555B2 (en) 2008-08-11 2013-11-26 Emd Millipore Corporation Immunoglobulin-binding proteins with improved specificity
SG195555A1 (en) * 2008-12-24 2013-12-30 Emd Millipore Corp Caustic stable chromatography ligands
EP2389386A4 (fr) * 2009-01-12 2013-11-06 Ge Healthcare Bio Sciences Ab Matrice de chromatographie par affinité
EP2412809B1 (fr) * 2009-03-24 2017-08-09 Kaneka Corporation Protéine dotée d'une affinité pour l'immunoglobuline, et ligand d'affinité se liant à l'immunoglobuline
PL2414387T3 (pl) 2009-04-03 2016-06-30 Univ Chicago Kompozycje i sposoby związane z wariantami białka A (SpA)
AU2011222991B2 (en) 2010-03-05 2015-07-16 Boehringer Ingelheim International Gmbh Selective enrichment of antibodies
KR20130093084A (ko) 2010-07-02 2013-08-21 더 유니버시티 오브 시카고 단백질 Ａ(ＳｐＡ) 변이체와 관련된 조성물 및 방법
AU2011322657C1 (en) * 2010-10-27 2015-11-12 Spiber Technologies Ab Spider silk fusion protein structures for binding to an organic target
SG10201604559TA (en) 2011-06-08 2016-07-28 Emd Millipore Corp Chromatography matrices including novel staphylococcus aureus protein a based ligands
EP2744517B1 (fr) 2011-08-15 2019-03-13 The University of Chicago Compositions et procédés liés aux anticorps anti-protéine a du staphylocoque
WO2013081540A1 (fr) * 2011-11-30 2013-06-06 Ge Healthcare Bio-Sciences Ab Matrice de chromatographie par affinité
CN103014880B (zh) 2012-12-20 2015-06-24 天津大学 基于蛋白a亲和模型构建免疫球蛋白g的亲和配基多肽库及设计方法的应用
KR20150011231A (ko) * 2013-07-22 2015-01-30 삼성디스플레이 주식회사 유기 발광 표시 장치 및 이의 제조 방법
EP3023777B1 (fr) 2013-09-09 2017-11-15 Shimadzu Corporation Procédés de préparation de fragments peptidiques, kit de préparation de fragments peptidiques destiné à être utilisé dans celui-ci, et procédé d'analyse
EP3094391A4 (fr) 2014-01-17 2017-09-20 Repligen Corporation Stérilisation de colonnes chromatographiques
CN105198973B (zh) * 2014-06-18 2019-01-25 上海交通大学 一种葡萄球菌a蛋白z结构域衍生物及其应用
US11566082B2 (en) 2014-11-17 2023-01-31 Cytiva Bioprocess R&D Ab Mutated immunoglobulin-binding polypeptides
EP3276002B1 (fr) * 2015-03-26 2020-04-29 JSR Corporation Protéine de liaison à l'immunoglobuline, et support d'affinité mettant en oeuvre celle-ci
CN107923889A (zh) * 2015-07-28 2018-04-17 Jsr株式会社 亲和载体和将免疫球蛋白分离的方法
US10730908B2 (en) 2016-05-11 2020-08-04 Ge Healthcare Bioprocess R&D Ab Separation method
US11753438B2 (en) 2016-05-11 2023-09-12 Cytiva Bioprocess R&D Ab Method of cleaning and/or sanitizing a separation matrix
US10889615B2 (en) 2016-05-11 2021-01-12 Cytiva Bioprocess R&D Ab Mutated immunoglobulin-binding polypeptides
ES2874974T3 (es) 2016-05-11 2021-11-05 Cytiva Bioprocess R & D Ab Matriz de separación
CN109311949B (zh) 2016-05-11 2022-09-16 思拓凡生物工艺研发有限公司 储存分离基质的方法
US10703774B2 (en) 2016-09-30 2020-07-07 Ge Healthcare Bioprocess R&D Ab Separation method
AU2017311541B2 (en) * 2016-08-11 2020-08-13 Navigo Proteins Gmbh Novel alkaline stable immunoglobulin-binding proteins
EP3521304B9 (fr) * 2018-02-01 2023-10-04 Repligen Corporation Protéines de liaison fc avec la cystéine dans la région hélicoïdale c-terminale
AU2018314651B2 (en) 2017-08-07 2022-12-15 Repligen Corporation Fc binding proteins with Cysteine in the C-terminal helical region
JP7479383B2 (ja) 2018-09-27 2024-05-08 エクシリオ デベロップメント， インコーポレイテッド マスクされたサイトカインポリペプチド
CA3135846A1 (fr) * 2019-04-02 2020-10-08 Bondwell Technologies Inc. Materiaux de proteine ubx fonctionnalises pour purification amelioree d'anticorps
CN111057153B (zh) * 2019-12-06 2021-09-07 广州康盛生物科技股份有限公司 一种免疫球蛋白结合蛋白及其制备方法和应用
CN110950969B (zh) * 2019-12-23 2021-03-30 北京全式金生物技术有限公司 一种具有免疫球蛋白结合能力的融合蛋白
GB202113626D0 (en) 2021-09-24 2021-11-10 Cytiva Bioprocess R & D Ab FC binding polypeptides
CN114409801B (zh) * 2021-12-22 2023-04-18 苏州赛分科技股份有限公司 基于重组蛋白a的亲和层析介质及其制备方法和应用
GB202203478D0 (en) 2022-03-14 2022-04-27 Cytiva Bioprocess R & D Ab Vh3 binding polypeptides

Family Cites Families (66)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE462046C (sv) 1982-08-23 1998-04-27 Pharmacia Biotech Ab Hybrid-DNA-vektor innehållande DNA-sekvens från Staphylococcus aureus, förfarande för dess framställning och bakterie innehållande densamma
US5151350A (en) * 1982-10-27 1992-09-29 Repligen Corporation Cloned genes encoding recombinant protein a
US4617266A (en) * 1983-04-28 1986-10-14 Genex Corporation Production of Protein A
SE8505922D0 (sv) * 1985-12-13 1985-12-13 Kabigen Ab Construction of an igg binding protein to facilitate downstream processing using protein engineering
US5260373A (en) * 1987-03-13 1993-11-09 Repligen Corporation Immobilized immunoglobulin-binding proteins
US5084559A (en) * 1987-03-27 1992-01-28 Repligen Corporation Protein a domain mutants
US5089473A (en) 1988-08-29 1992-02-18 Monsanto Company Somatotropin variants and their use
GB8902770D0 (en) 1989-02-08 1989-03-30 Bioprocessing Ltd Improvements in or relating to supports for immunoaffinity separations
US4879378A (en) * 1989-03-30 1989-11-07 Union Carbide Chemicals And Plastics Company Inc. Polysiloxanes with pendant sterically hindered phenol moiety connected to the silicon atom via a carbonylyoxy-containing link
US5401650A (en) * 1990-10-24 1995-03-28 The Mount Sinai School Of Medicine Of The City University Of New York Cloning and expression of biologically active α-galactosidase A
US5198531A (en) * 1991-06-14 1993-03-30 Research Diagnostic Antibodies Polymeric resin for peptide synthesis
EP0550771B1 (fr) 1991-07-25 1999-09-29 Oriental Yeast Co., Ltd. Protein artificielle de liaison avec les immunoglobulines
US5240680A (en) * 1991-12-19 1993-08-31 Chiron Corporation Automated apparatus for use in peptide synthesis
US5573905A (en) * 1992-03-30 1996-11-12 The Scripps Research Institute Encoded combinatorial chemical libraries
SE9400088D0 (sv) 1994-01-14 1994-01-14 Kabi Pharmacia Ab Bacterial receptor structures
SE9503925D0 (sv) 1995-11-07 1995-11-07 Pharmacia Biotech Ab Separationsmedium för IgG
AU2429397A (en) 1996-03-29 1997-10-22 David S. Terman Polymerized staphylococcal protein a for treatment of diseases
US6013763A (en) 1996-06-04 2000-01-11 Genentech, Inc. Peptide variants of protein A
US5856452A (en) * 1996-12-16 1999-01-05 Sembiosys Genetics Inc. Oil bodies and associated proteins as affinity matrices
US7026446B1 (en) * 1997-12-24 2006-04-11 Diatech Pty Ltd. Bifunctional molecules
GB9823071D0 (en) 1998-10-21 1998-12-16 Affibody Technology Ab A method
US6589529B1 (en) * 1998-10-30 2003-07-08 Children's Hospital Medical Center Rotavirus subunit vaccine
US6602977B1 (en) * 1999-04-19 2003-08-05 Biovitrum Ab Receptor structures
SE9901379D0 (sv) 1999-04-19 1999-04-19 Pharmacia & Upjohn Ab Receptor structures
CA2374013A1 (fr) * 1999-05-15 2000-11-23 University Of California, San Diego Domaines avec activites voulues fondes sur la proteine a
US7163686B1 (en) * 1999-05-15 2007-01-16 The Regents Of The University Of California Protein A based binding domains with desirable activities
EP3960855A1 (fr) 2001-12-28 2022-03-02 Chugai Seiyaku Kabushiki Kaisha Procédé de stabilisation de protéines
US7709209B2 (en) * 2002-03-25 2010-05-04 Ge Healthcare Bio-Sciences Ab Protein ligands
SE0200943D0 (sv) 2002-03-25 2002-03-25 Amersham Biosciences Ab Mutant protein
US7083948B1 (en) * 2002-12-24 2006-08-01 Immunex Corporation Polypeptide purification reagents and methods for their use
DK1601697T3 (da) 2003-02-28 2007-10-01 Lonza Biologics Plc Oprensning af antistof ved protein A- og ionbytningskromatografi
GB0304576D0 (en) * 2003-02-28 2003-04-02 Lonza Biologics Plc Protein a chromatography
EP1641818B1 (fr) 2003-07-04 2008-12-03 Affibody AB Polypeptides presentant une affinite de liaison pour le recepteur 2 du facteur de croissance epidermique humain (her2)
US7956165B2 (en) * 2003-07-24 2011-06-07 Affisink Biotechnology Ltd. Compositions and methods for purifying and crystallizing molecules of interest
WO2005033132A2 (fr) * 2003-10-03 2005-04-14 Genentech, Inc. Proteines de liaison a l'igf
EP1564286A1 (fr) 2004-02-11 2005-08-17 Université de Liège Protéines hybrides de la beta-lactamase classe A
EP2251425B1 (fr) 2004-07-06 2016-04-20 Kaneka Corporation Procédé de production d'un assimilé de la protéine A à l'aide de bactérie Brevibacillus
US8728828B2 (en) * 2004-12-22 2014-05-20 Ge Healthcare Bio-Sciences Ab Purification of immunoglobulins
US20080254551A1 (en) 2004-12-30 2008-10-16 Achsel Tilmann Immunoprecipitaion-Based Method to Purify and Characterise Biological Macromolecular Complexes
ATE490268T1 (de) 2005-03-01 2010-12-15 Affibody Ab Tnf-alhpa-bindendes polypeptid, anwendungen davon und verfahren, bei denen dieses verwendet wird
JP2006304633A (ja) 2005-04-26 2006-11-09 Apro Life Science Institute Inc イムノグロブリン結合タンパク質
ES2402650T3 (es) 2005-06-17 2013-05-07 Janssen Alzheimer Immunotherapy Métodos de purificación de anticuerpos anti A beta
US20100015044A1 (en) 2005-08-03 2010-01-21 Robert Qiu Methods and compositions for diagnosis of iga-and igm-mediated kidney diseases
KR101289911B1 (ko) 2005-08-03 2013-07-26 메르크 파텐트 게엠베하 친수성 가교 중합체
US8440191B2 (en) * 2005-11-18 2013-05-14 Tufts Medical Center Clearance of abnormal IGA1 in IGA1 deposition diseases
EP1974215B1 (fr) * 2006-01-06 2017-12-27 EMD Millipore Corporation Matrices de chromatographie d'affinite et procedes de fabrication et d'utilisation correspondants
WO2007097361A1 (fr) 2006-02-21 2007-08-30 Protenova Co., Ltd. Ligand presentant une affinite pour les immunoglobulines
US20080096819A1 (en) * 2006-05-02 2008-04-24 Allozyne, Inc. Amino acid substituted molecules
GB0610776D0 (en) 2006-05-31 2006-07-12 Univ Bath Novel applications for staphylococcus aureus Sbi protein
US8329860B2 (en) 2006-09-29 2012-12-11 Ge Healthcare Bio-Sciences Ab Chromatography ligand comprising domain C from Staphylococcus aureus protein A for antibody isolation
JP5004165B2 (ja) * 2006-10-10 2012-08-22 独立行政法人産業技術総合研究所 タンパク質の配向制御固定化に適したタンパク質
EP2099932A4 (fr) * 2006-12-06 2009-11-18 Repligen Corp Acides nucleiques codant pour la proteine recombinee a
US8362217B2 (en) * 2006-12-21 2013-01-29 Emd Millipore Corporation Purification of proteins
NZ577933A (en) 2007-01-22 2011-12-22 Genentech Inc Polyelectrolyte precipitation and purification of antibodies
JP2008255046A (ja) 2007-04-04 2008-10-23 Toray Ind Inc 融合タンパク質、これを用いた抗体捕捉担体および抗原検出法
JP2008266221A (ja) * 2007-04-20 2008-11-06 National Institute Of Advanced Industrial & Technology アミノ末端１箇所で配向制御固定化された固定化タンパク質
US8198409B2 (en) * 2007-05-21 2012-06-12 Nomadic Bioscience Co., Ltd. Polypeptide, an affinity chromatography material, and a method for separating and/or purifying immunoglobulin
SG149759A1 (en) * 2007-07-10 2009-02-27 Millipore Corp Media for affinity chromatography
CN102027010A (zh) 2008-05-15 2011-04-20 诺沃-诺迪斯克有限公司 抗体纯化方法
JP5677943B2 (ja) 2008-06-05 2015-02-25 アフィボディ・アーベーＡｆｆｉｂｏｄｙ Ａｂ ポリペプチド
US8592555B2 (en) 2008-08-11 2013-11-26 Emd Millipore Corporation Immunoglobulin-binding proteins with improved specificity
SG195555A1 (en) * 2008-12-24 2013-12-30 Emd Millipore Corp Caustic stable chromatography ligands
EP2389386A4 (fr) 2009-01-12 2013-11-06 Ge Healthcare Bio Sciences Ab Matrice de chromatographie par affinité
EP2412809B1 (fr) 2009-03-24 2017-08-09 Kaneka Corporation Protéine dotée d'une affinité pour l'immunoglobuline, et ligand d'affinité se liant à l'immunoglobuline
JP2014502272A (ja) 2010-11-29 2014-01-30 ジーイー・ヘルスケア・バイオサイエンス・アクチボラグ アフィニティークロマトグラフィーマトリックス
SG10201604559TA (en) 2011-06-08 2016-07-28 Emd Millipore Corp Chromatography matrices including novel staphylococcus aureus protein a based ligands

Also Published As

Publication number Publication date
JP6181145B2 (ja) 2017-08-16
CN104804073B (zh) 2018-11-27
US8592555B2 (en) 2013-11-26
EP2157099B1 (fr) 2016-12-21
JP5913202B2 (ja) 2016-04-27
SG193852A1 (en) 2013-10-30
JP2010075175A (ja) 2010-04-08
ES2612138T3 (es) 2017-05-12
US9920112B2 (en) 2018-03-20
CN104163866A (zh) 2014-11-26
JP5480558B2 (ja) 2014-04-23
US20140046037A1 (en) 2014-02-13
JP2016121152A (ja) 2016-07-07
EP2495254B1 (fr) 2016-12-21
ES2612166T3 (es) 2017-05-12
EP2157099A1 (fr) 2010-02-24
EP2495253A1 (fr) 2012-09-05
EP2495254A1 (fr) 2012-09-05
CN104804073A (zh) 2015-07-29
IN2015DE00245A (fr) 2015-07-17
US20100063256A1 (en) 2010-03-11
JP2013226148A (ja) 2013-11-07
CN101704879B (zh) 2015-04-08
ES2612114T3 (es) 2017-05-12
CN101704879A (zh) 2010-05-12
EP2495253B1 (fr) 2016-12-21

Similar Documents

Publication Publication Date Title
SG159458A1 (en) Novel immunoglobulin-binding proteins with improved specificity
SG162687A1 (en) Caustic stable chromatography ligands
CY1121208T1 (el) Σκευασματα αντισωματος ναταλιζουμαμπης
WO2014059442A3 (fr) Réactifs à base d'anticorps qui reconnaissent spécifiquement des formes oligomériques toxiques de tau
WO2013138793A3 (fr) Réactifs d'affinité pour la purification de protéines
WO2012058308A3 (fr) Reactif à base d'anticorps reconnaissant spécifiquement une forme oligomérique toxique de beta-amyloïde
EA200970909A1 (ru) Новый антиген, ассоциированный с новообразованными сосудами опухолевых метастазов
TN2010000213A1 (en) Wise binding antibodies and epitopes
MX2011011925A (es) Anticuerpos triespecificos o tetraespecificos.
MX2010005682A (es) Anticuerpos bivalentes, biespecificos.
MX2010005888A (es) Anticuerpos bivalentes biespecificos.
UA100874C2 (en) Bivalent bispecific antibodies
EA201291065A1 (ru) Антитела против vla-4
IN2015MN00139A (fr)
MX2009004167A (es) Anticuerpos que enlazan epitopos cxcr7.
UA111818C2 (uk) Антитіло проти csf-1r
WO2011047146A3 (fr) Procédés de maturation d'affinité d'anticorps
MX2015006548A (es) Proteinas vinculantes que comprenden al menos dos dominios de repeticion contra her2.
MY161435A (en) Anti-vegf antibodies and polynucleotides encoding the same
EA201790757A1 (ru) Связывающие антиген cd27l белки
PH12013502205A1 (en) Antibodies to il-6 and their uses
EA201390923A1 (ru) Модифицированное антитело с улучшенным полупериодом существования
MX342034B (es) Proteinas monovalentes que se unen a antigenos.
MX2012000765A (es) Dominios variables sencillos de union de albumina anti-suero mejorados.
MX2010008688A (es) Anticuerpos anti-receptor de linfopoyetina estromal timica procesados por ingenieria.